Gabriel Sung is an experienced pharmaceutical marketing professional with a strong background in oncology, hematology, and immunology. Currently serving as the Global Commercial Head for HER2-directed Solid Tumors at AstraZeneca since June 2015, Gabriel develops and drives commercialization plans for various indications. Prior roles at AstraZeneca include Global Commercial Director for Lung Cancer and US Marketing Director for Hematology. Previously, Gabriel held multiple positions at Boehringer Ingelheim, focusing on new product commercialization and marketing strategy across various therapeutic areas. Early career experiences include roles at Bristol Myers Squibb and DuPont Pharmaceuticals Co., supporting drug discovery and development. Gabriel holds an MBA in Marketing and Strategy from Yale School of Management, a Master's degree in Synthetic Organic Chemistry from the University of Calgary, and a Bachelor's degree in Biochemistry from Mount Allison University.
This person is not in any teams
This person is not in any offices